Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.1.9
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
COSTS AND EXPENSES:    
Research and development $ 18,617us-gaap_ResearchAndDevelopmentExpense $ 4,650us-gaap_ResearchAndDevelopmentExpense
General and administrative 9,039us-gaap_GeneralAndAdministrativeExpense 6,238us-gaap_GeneralAndAdministrativeExpense
Total operating expenses 27,656us-gaap_OperatingExpenses 10,888us-gaap_OperatingExpenses
Operating Loss (27,656)us-gaap_OperatingIncomeLoss (10,888)us-gaap_OperatingIncomeLoss
Interest income, net 40us-gaap_InterestIncomeExpenseNet 4us-gaap_InterestIncomeExpenseNet
NET LOSS $ (27,616)us-gaap_NetIncomeLoss $ (10,884)us-gaap_NetIncomeLoss
Net loss per common share, basic and diluted (in dollars per share) $ (2.77)us-gaap_EarningsPerShareBasicAndDiluted $ (3.37)us-gaap_EarningsPerShareBasicAndDiluted
Weighted average common shares outstanding, basic and diluted (in shares) 9,985,515us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 3,231,311us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted